Journal article

High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma

Chan Yoon Cheah, David Joske, Gavin Cull, Michael Gilbertson, Stephen S Opat, Constantine S Tam, Andrew Wirth, John F Seymour

British Journal of Haematology | WILEY | Published : 2017

DOI: 10.1111/bjh.14187

Citation metrics

2Web of Science
3Scopus

Keywords

Trial
Involvement
Humans
Antineoplastic Combined Chemotherapy Protocols
Autologous Stem Cell Transplant
Rituximab
Patient Selection
Science & Technology
Treatment Outcome
Non-Hodgkin-Lymphoma
Diffuse Large B-Cell Lymphoma
Phase-Ii
Life Sciences & Biomedicine
Transplantation, Autologous
Hematology
Lymphoma, Large B-Cell, Diffuse
Prophylaxis
Survival Analysis
Central Nervous System Neoplasms
Central Nervous System
Hematopoietic Stem Cell Transplantation